AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2018
Jan 25, 2018
34395_dirs_2018-01-25_d626f418-4a21-4765-9825-67e618ab4f47.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2018-01-23
Reporting Person: Skaff Habib (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-01-23 | Stock Option (Right to Buy) | $4 | A | 10000 | Acquired | 2024-01-23 | Common Stock (10000) | Direct |
Footnotes
F1: A total of 10,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.